NP
PFE icon

NorthRock Partners’s Pfizer PFE Stock Holding History

NorthRock Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$676K Buy
24,079
+3,246
+16% +$86.4K 0.01% 366
2025
Q4 		$519K Sell
20,833
-55,645
-73% -$1.4M 0.01% 362
2025
Q3 		$1.95M Buy
76,478
+9,827
+15% +$243K 0.04% 215
2025
Q2 		$1.62M Buy
66,651
+18,323
+38% +$427K 0.04% 161
2025
Q1 		$1.22M Sell
48,328
-1,822
-4% -$47.7K 0.04% 178
2024
Q4 		$1.33M Sell
50,150
-20,314
-29% -$551K 0.04% 164
2024
Q3 		$2.04M Buy
70,464
+5,392
+8% +$157K 0.07% 124
2024
Q2 		$1.82M Buy
65,072
+778
+1% +$21.4K 0.07% 121
2024
Q1 		$1.78M Buy
64,294
+3,996
+7% +$111K 0.07% 134
2023
Q4 		$1.74M Buy
60,298
+27,039
+81% +$817K 0.07% 134
2023
Q3 		$1.1M Buy
33,259
+3,281
+11% +$116K 0.12% 93
2023
Q2 		$1.1M Buy
29,978
+2,178
+8% +$84.8K 0.12% 81
2023
Q1 		$1.13M Sell
27,800
-6,730
-19% -$291K 0.12% 84
2022
Q4 		$1.77M Buy
34,530
+108
+0.3% +$5.18K 0.2% 55
2022
Q3 		$1.51M Sell
34,422
-3,994
-10% -$194K 0.18% 61
2022
Q2 		$2.01M Buy
38,416
+2,687
+8% +$137K 0.21% 50
2022
Q1 		$1.85M Buy
35,729
+2,544
+8% +$132K 0.17% 63
2021
Q4 		$1.96M Buy
33,185
+6,079
+22% +$301K 0.15% 63
2021
Q3 		$1.17M Sell
27,106
-3,959
-13% -$175K 0.1% 84
2021
Q2 		$1.22M Sell
31,065
-5,836
-16% -$227K 0.1% 74
2021
Q1 		$1.34M Buy
36,901
+13,107
+55% +$465K 0.12% 67
2020
Q4 		$876K Sell
23,794
-4,606
-16% -$169K 0.09% 84
2020
Q3 		$989K Buy
28,400
+6,869
+32% +$241K 0.11% 79
2020
Q2 		$668K Buy
21,531
+4,885
+29% +$166K 0.08% 100
2020
Q1 		$515K Sell
16,646
-19,537
-54% -$666K 0.07% 107
2019
Q4 		$1.34M Buy
36,183
+6,819
+23% +$243K 0.14% 88
2019
Q3 		$1M Buy
+29,364
New +$1.07M 0.14% 85
2019
Q1 		– Sell
-8,846
Closed -$365K – 103
2018
Q4 		$365K Buy
+8,846
New +$367K 0.11% 52

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

NorthRock Partners's PFE Position: Q1 2026 in Review

NorthRock Partners increased its Pfizer (PFE) stake by 16% in Q1 2026, buying an estimated $86.4K and bringing the position to 24,079 shares worth $676K. The position accounts for 0.01% of the portfolio, ranked #366.

NorthRock Partners first reported a position in PFE in Q4 2018 and has held it in 28 quarters since. The position peaked at $2.04M in Q3 2024. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • NorthRock Partners held 24,079 shares of Pfizer worth $676K as of Q1 2026.
  • NorthRock Partners bought 3,246 Pfizer shares in Q1 2026, an estimated $86.4K.
  • Pfizer made up 0.01% of NorthRock Partners's portfolio in Q1 2026, its #366 holding.
  • NorthRock Partners first reported a position in Pfizer in Q4 2018 and has held it in 28 quarters since.
  • NorthRock Partners's Pfizer position peaked at $2.04M in Q3 2024.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.